Patent classifications
C07C13/66
Polymer, composition for organic electroluminescent element, organic electroluminescent element, organic EL display device, and organic EL lighting device
The object of the present invention is to provide a polymer capable of being insolubilized at a low temperature in a short time, having a high hole injecting and transporting ability and a high durability, and a composition for organic electroluminescent element comprising the polymer. The polymer of the present invention comprises a specific crosslinkable group.
Organic electroluminescence device and anthracene derivative
An organic electroluminescence device which comprises a cathode, an anode and an organic thin film layer comprising at least one layer comprising a light emitting layer and disposed between the cathode and the anode, wherein at least one layer in the organic thin film layer comprises an anthracene derivative having a specific structure singly or as a component of a mixture, and an anthracene derivative having a specific asymmetric structure and providing an organic electroluminescence device exhibiting a great efficiency of light emission and having a long life, are provided.
Organic electroluminescence device and anthracene derivative
An organic electroluminescence device which comprises a cathode, an anode and an organic thin film layer comprising at least one layer comprising a light emitting layer and disposed between the cathode and the anode, wherein at least one layer in the organic thin film layer comprises an anthracene derivative having a specific structure singly or as a component of a mixture, and an anthracene derivative having a specific asymmetric structure and providing an organic electroluminescence device exhibiting a great efficiency of light emission and having a long life, are provided.
ORGANIC ELECTRON TRANSPORT MATERIAL
The present invention relates to an organic electron transport material having a compound of the structure shown in formula (I), wherein R1-R4 independently represent hydrogen, C1-C8 substituted or substituted alkyl, C2-C8 substituted or unsubstituted alkenyl, or C2-C8 substituted or unsubstituted alkynyl, the substituents being C1-C4 alkyl or halogen. Device experiments show that an electronic-only organic semiconductor diode device and an organic electroluminescent device manufactured by the organic electron transport material of the present invention have good electron transport performance, high and stable luminance, and a long device life.
ORGANIC ELECTRON TRANSPORT MATERIAL
The present invention relates to an organic electron transport material having a compound of the structure shown in formula (I), wherein R1-R4 independently represent hydrogen, C1-C8 substituted or substituted alkyl, C2-C8 substituted or unsubstituted alkenyl, or C2-C8 substituted or unsubstituted alkynyl, the substituents being C1-C4 alkyl or halogen. Device experiments show that an electronic-only organic semiconductor diode device and an organic electroluminescent device manufactured by the organic electron transport material of the present invention have good electron transport performance, high and stable luminance, and a long device life.
Organic electroluminescent element and electronic device
An organic electroluminescence device includes an anode, a cathode, and an emitting layer, in which the emitting layer contains a first compound, a second compound, and a third compound, a singlet energy S(M1) of the first compound and a singlet energy S(M2) of the second compound satisfy a numerical formula (Numerical Formula 1) below, an electron affinity Af(M1) of the first compound and an electron affinity Af(M2) of the second compound satisfy a numerical formula (Numerical Formula 2) below, and a triplet energy T(M1) of the first compound satisfies a numerical formula (Numerical Formula 3) below,
S(M2)S(M1)0.95(Numerical Formula 1)
Af (M2)Af(M1)0.2eV(Numerical Formula 2)
T(M1)2.0eV(Numerical Formula 3).
Organic electroluminescent element and electronic device
An organic electroluminescence device includes an anode, a cathode, and an emitting layer, in which the emitting layer contains a first compound, a second compound, and a third compound, a singlet energy S(M1) of the first compound and a singlet energy S(M2) of the second compound satisfy a numerical formula (Numerical Formula 1) below, an electron affinity Af(M1) of the first compound and an electron affinity Af(M2) of the second compound satisfy a numerical formula (Numerical Formula 2) below, and a triplet energy T(M1) of the first compound satisfies a numerical formula (Numerical Formula 3) below,
S(M2)S(M1)0.95(Numerical Formula 1)
Af (M2)Af(M1)0.2eV(Numerical Formula 2)
T(M1)2.0eV(Numerical Formula 3).
PYRENE DERIVATIVE, ORGANIC LIGHT-EMITTING MEDIUM, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING PYRENE DERIVATIVE OR ORGANIC LIGHT-EMITTING MEDIUM
An organic light-emitting medium including a pyrene derivative represented by the following formula (1) and a phenyl-substituted anthracene derivative represented by the following formula (2):
##STR00001##
wherein Ar.sup.1 to Ar.sup.4 are independently a substituted or unsubstituted aryl group having 6 to 30 ring carbon atoms or a substituted or unsubstituted heteroaryl group having 5 to 20 ring atoms.
PYRENE DERIVATIVE, ORGANIC LIGHT-EMITTING MEDIUM, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING PYRENE DERIVATIVE OR ORGANIC LIGHT-EMITTING MEDIUM
An organic light-emitting medium including a pyrene derivative represented by the following formula (1) and a phenyl-substituted anthracene derivative represented by the following formula (2):
##STR00001##
wherein Ar.sup.1 to Ar.sup.4 are independently a substituted or unsubstituted aryl group having 6 to 30 ring carbon atoms or a substituted or unsubstituted heteroaryl group having 5 to 20 ring atoms.
DNA BINDING AGENTS WITH A MINOR GROOVE BINDING TAIL
Provided herein are compounds which intercalate into the DNA of a cell and are capable of crossing the blood brain barrier of a formula provided herein. Pharmaceutical compositions of the compounds and methods of treating cancer, for example brain, lung, or pancreatic cancer, are also provided herein.